Marshall Wace North America’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Marshall Wace North America's AMGN Position: Q3 2021 in Review
Marshall Wace North America sold out of Amgen (AMGN) in Q3 2021, closing a stake of 63,921 shares — an estimated $15.6M sold.
Marshall Wace North America first reported a position in AMGN in Q3 2013 and held it in 14 quarters. The position peaked at $63.7M in Q2 2020. 2,134 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.
- Marshall Wace North America reported no remaining Amgen position as of Q3 2021 after selling out during the quarter.
- Marshall Wace North America sold 63,921 Amgen shares in Q3 2021, an estimated $15.6M.
- Marshall Wace North America first reported a position in Amgen in Q3 2013 and held it in 14 quarters.
- Marshall Wace North America's Amgen position peaked at $63.7M in Q2 2020.
- 2,134 funds tracked by Wall St. Rank held Amgen as of Q3 2021.
Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.